Ready 8-Ks
25
Latest filing
April 28, 2026, 7:59 PM ET
Top materiality
0.80
Event mix
earnings ×9 · debt ×9 · other_material ×2
Sentiment
6 pos · 1 neg · 18 neu
Latest earnings
reported 2026-Q1
-
Sherwin-Williams Q1 net sales +6.8% to $5.67B, adj. EPS $2.35 +4.4%; reaffirms FY guidance
Consolidated net sales $5.67B (+6.8% YoY); diluted EPS $2.15 (+7.5%); adjusted EPS $2.35 (+4.4%).
-
Sherwin-Williams Q4 adj EPS $2.23, record FY sales $23.57B; guides FY26 adj EPS $11.50-$11.90
Q4 adj diluted EPS $2.23 (+6.7% YoY); net sales $5.60B (+5.6% YoY), including Suvinil contribution $164.5M.
-
Sherwin-Williams names Benjamin Meisenzahl as CFO; current CFO Mistysyn to retire
Allen J. Mistysyn to retire as SVP-Finance and CFO effective Dec 31, 2025 after 35 years; will assume short-term non-officer role.
-
Sherwin-Williams Q3 net sales +3.2% to $6.36B, adj. EPS $3.59; narrows FY25 guidance
Diluted GAAP EPS $3.35 vs $3.18 YoY (+5.3%); adjusted EPS $3.59 vs $3.37 (+6.5%).
-
Sherwin-Williams closes $1.15B acquisition of BASF's Brazilian paints business (Suvinil)
Acquired all equity interests in Suvinil Coatings S.A. (formerly BASF Coatings S.A.) for $1.15B.
-
Sherwin-Williams issues $1.5B senior notes in three tranches
$500M of 4.300% Senior Notes due 2028, $500M of 4.500% due 2030, $500M of 5.150% due 2035.
-
Sherwin-Williams Q2 EPS $3.00 (-14.3% YoY); full-year guidance cut to $10.11-$10.41
Consolidated net sales up 0.7% to $6.31B; diluted EPS down 14.3% to $3.00; adjusted EPS down 8.6% to $3.38.
-
Sherwin-Williams Q1 sales -1.1% to $5.31B; adj. EPS +3.7% to $2.25; FY guidance reaffirmed
Consolidated net sales $5.31B (-1.1% YoY); GAAP diluted EPS $2.00 (+1.5%); adj. diluted EPS $2.25 (+3.7%).
-
Sherwin-Williams to acquire BASF's decorative paints business in Brazil for $1.15B cash
Wholly owned subsidiary Sherwin-Williams do Brasil to acquire all equity of BASF Coatings S.A. for $1.15B cash, subject to customary adjustments.
-
Sherwin-Williams posts record FY2024 sales of $23.1B, adj. EPS up 9.5% to $11.33, guides FY2025 adj. EPS $11.65-$12.05
FY2024 diluted EPS $10.55 (+14.1% YoY); adjusted diluted EPS $11.33 (+9.5%); net sales record $23.10B.
-
Sherwin-Williams Q3 2024: EPS $3.18, sales up 0.7% to $6.16B; reaffirms FY guidance
Consolidated net sales $6.16B (+0.7%); diluted EPS $3.18 (+7.8%), adjusted EPS $3.37 (+5.3%).
-
Sherwin-Williams Q2 adjusted EPS $3.70, up 12.5%; raises full-year guidance
Consolidated net sales $6.27B (+0.5% YoY); diluted EPS $3.50 (+14%), adj. EPS $3.70 (+12.5%), EBITDA $1.44B (+12.1%).
-
Sherwin-Williams Q1 adjusted EPS $2.17 beats $2.04 YoY; reaffirms FY2024 guidance
Consolidated net sales down 1.4% to $5.37B; diluted EPS rose 7.1% to $1.97, adjusted EPS up 6.4% to $2.17.